NCT02189122View on ClinicalTrials.gov

Comparative Effects of Aspirin and NHP-544C

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Healthy
Interventions
DRUG

Bradykinin

Bradykinin will be given intravenously in graded doses. Each dose will be given for 15 minutes.

DRUG

Aspirin 81 mg

Subjects will take Aspirin 81 mg per day for five days.

DRUG

Aspirin 162 mg

Subjects will take aspirin 162 mg per day for 5 days.

DRUG

NHP544-C 81 mg

Subjects will take NHP544C 81 mg per day for five days.

DRUG

NHP544C 162 mg

Subjects will take NHP544C 162 mg once a day for five days.

DRUG

Placebo

Subjects will take matching placebo for five days.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT02189122 - Comparative Effects of Aspirin and NHP-544C | Biotech Hunter | Biotech Hunter